Skip to the primary navigation.
Skip to the content.

Home
Product
Development Plan
Who We Are
News

Press Releases

September 21, 2021 9:00 am

Veltion Therapeutics Receives Phase I STTR for Fibrosis Research

Veltion Therapeutics LLC
3401 Grays Ferry Ave #1048
Philadelphia, PA 19146-2701 LLC

© 2024 Veltion Therapeutics